Abpro Holdings, Inc. (ABPO)
0.2293
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Abpro Holdings Total Assets (Quarterly) : 5.241M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.241M |
| March 31, 2026 | 6.865M |
| December 31, 2025 | 1.063M |
| September 30, 2025 | 1.703M |
| June 30, 2025 | 3.483M |
| March 31, 2025 | 2.797M |
| December 31, 2024 | 4.661M |
| September 30, 2024 | 7.858M |
| June 30, 2024 | 7.896M |
| March 31, 2024 | 7.534M |
| Date | Value |
|---|---|
| December 31, 2023 | 3.355M |
| September 30, 2023 | 37.52M |
| June 30, 2023 | 38.44M |
| March 31, 2023 | 313.65M |
| December 31, 2022 | 310.56M |
| September 30, 2022 | 308.23M |
| June 30, 2022 | 306.98M |
| March 31, 2022 | 306.90M |
| December 31, 2021 | 0.3614M |
| October 31, 2021 | 0.1756M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.225M |
| Shareholders Equity (Quarterly) | -3.533M |
| Debt to Equity Ratio | -0.0484 |
| Current Ratio | 0.6175 |
| Net Debt Paydown Yield | 52.38% |